SPENCER BLONDEAUX: Open Payments
NPI 1114645249 · BRIDGETON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,075 in 66 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $133 · 2025 $1,075
Food & beverage: $1,075
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $214 |
| PFIZER INC. | 15 | $169 |
| Lilly USA, LLC | 9 | $160 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $156 |
| Novo Nordisk Inc | 6 | $95 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Amgen Inc. | 2 | $35 |
| Boston Scientific Corporation | 1 | $34 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
Products named: XIFAXAN, VRAYLAR, NURTEC ODT, MOUNJARO, ELIQUIS, KISUNLA, Wegovy, GVOKE HYPOPEN.
Industry payments across MO — which companies pay providers there.
